echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Band volume purchase 500 varieties list outflow! 3 years full coverage, trillion market reconstruction!

    Band volume purchase 500 varieties list outflow! 3 years full coverage, trillion market reconstruction!

    • Last Update: 2020-08-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network July 29 According to industry news, the core content of the July 24 national collection meeting includes: the national collection and collection of three batches, followed by Shanghai led by the normal development;
    not carried out by the State, it is organized by the provincial organizations.
    in addition, chemical drugs, biological agents, traditional Chinese medicine should be included in the collection.
    trillion market reconstruction from the meeting revealed that the volume of procurement will achieve national, provincial and municipal full coverage, as well as varieties, categories of expansion coverage.
    the National Health Insurance Administration also stressed that the provinces do not worry about the flow of labels, flow-standard products reported to the National Health Insurance Administration in a timely manner, further study the reasons.
    up to now, the first batch of 25 varieties, the second batch of 32 varieties, the third batch has not yet officially released the catalog, but from the provincial report inglise and the recently released bottom list, a total of 56 varieties, a total of 113 varieties.
    has a voice pointed out that the current carryout of the volume of procurement of varieties are still relatively small, recruitment scale, volume is difficult to the industry's persistent disease "gold sales" caused fundamental changes.
    , therefore, increase the coverage of the volume of procurement has become the general trend.
    in accordance with the 2021 coverage of 250 varieties of the target, there are 137 varieties, is expected to become the country, provinces and cities this year and next year will become a key node of the volume procurement.
    the 500 drugs on the above list are mainly of the top 80 per cent of the purchase amount. In addition to a large number of chemicals, the
    list also involves a number of biological drugs, including recombinant human type II tumor necrosis factor receptor-antibody fusion protein, rituximatoma, querceon, bevalbazumab, and a number of insulin varieties.
    - and inner-city data show that in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (china's public medical institutions) end-use drug sales amounted to 137.594 billion yuan, up 4.14% YoY, the market expanded year by year, but the growth rate continued to slow.
    sales of chemical drugs amounted to 109.2922 billion yuan, up 5.77% YoY, while sales of traditional Chinese medicines were RMB283.018 billion, down 1.7% YoY.
    rough estimate, covering the first 80% or involving 110 billion yuan of the market, under the influence of the volume procurement, the market pattern will be disruptive changes, especially on the original varieties of far-reaching impact. How
    provincial rules are co-ordinated? It is reported that the third batch of volume procurement rules are basically finalized, is expected to open on August 18, the end of July will be issued implementation plans and rules.
    the rules governing the selection are basically the same as those of the second batch of countries, using a 1.8-fold fuse mechanism and a 50 per cent reduction in prices.
    at the same time that the national collection and mining rapid promotion, provincial and municipal volume procurement is also accelerating landing.
    , however, the provinces are not progressing, there are some fast-paced provinces, programmes, directories have been issued, some have not yet started.
    with the regularization of the volume of procurement, the national mining to the number of over-rated enterprises mainly varieties, the rest of the varieties are handed over to the province, the city to harvest.
    and for the emphasis on the "provinces do not worry about flow marks" problem, at present, the provincial flow of the situation is not much, the municipal volume procurement of the flow of the situation or more common.
    in the industry's view, compared to the national collection, local collection more frequent, from time to time there is a "soul bargain."
    for example, Shanxi 21 injections of the band procurement, enterprises all price reduction should be standard.
    the first batch of pharmaceutical procurement in Qinghai Province included a total of 59 varieties, involving antimicrobials, PPI, respiratory, cardiovascular drugs, covering chemical drugs, traditional Chinese medicine, biological products.
    there are some exclusive varieties, such as butyl benzene, sputum heat-clearing injections, kidney injections, etc., as well as Budinaid, oseltamivir and other clinically popular varieties.
    according to the results of publicity, 140 rules are selected (of which: 55 rules without limit hanging net, 6 standard belt quantity procurement, some popular varieties are mostly included in the non-quantity limit hanging net), 78 rules proposed alternative.
    for the next provinces and cities of the belt procurement, there is a view that the remaining 387 varieties, the provinces can arrange their own volume procurement, not included in the volume of procurement varieties, the provinces can directly price linkage, if repeated band, bargaining, or increase administrative costs.
    in addition, the provinces alone with volume procurement, whether the exclusive winning bid also caused speculation.
    if the exclusive bid, the price reduction is naturally very large, but raw materials, production capacity, supply will become a challenge.
    if in accordance with the national collection of ideas, can be selected by a number of enterprises, each enterprise share several provinces of the market, the price of varieties between enterprises may exist a certain price gap.
    so the follow-up also depends on provincial policies, as well as the market situation of enterprises in the provinces.
    it is understood that the results of the production of the province has been announced, Shanxi 21 injections for the exclusive winning bid, Qinghai provisions to be selected and proposed alternative manufacturers.
    the city-level volume of the issue of the volume of the procurement of the city-level, there have been news that the official level does not recommend the city-level to carry out volume procurement.
    later, there is a view that not prohibitthed land and city volume procurement, but to standardize the filing.
    indeed, if the size of procurement in the city is small, the amount of the enterprise is not attractive enough, the enterprise should bid low, the effect of the volume procurement is not ideal.
    for example, recently in Jinhua City, Zhejiang Province, issued "on the development of Jinhua City, the second batch of drug tape procurement announcement", the number of imported procurement regulations as many as 274, the procurement scale of unprecedented, including many original research varieties, and the exclusive large varieties of Chinese medicine.
    but from the end result, only 93 standards should be marked, the rate should be only 3 percent, the original research drug is a collective abandonment of the standard.
    in the industry's view, the market area procurement too much, enterprises are often tired to deal with, coupled with increased administrative, organizational costs will be transformed into drug prices.
    on whether to reduce prices should be marked, business concerns mainly focus on the amount of can be guaranteed.
    for the accelerated development of belt procurement, there are enterprises believe that enterprises should have a clear understanding of the volume of procurement, such as the future of a product market to be how big, if sales of more than 300 million yuan, the future may be dangerous, not only by competitors, but also in the health care level will be limited.
    it is recommended that enterprises in the sub-sector to create a few small varieties with high technical content, so that may be able to maintain the product for a period of time.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.